Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms ; volume:13 ; number:1 ; day:15 ; month:11 ; year:2022 ; pages:1-20 ; date:12.2022
Nature Communications ; 13, Heft 1 (15.11.2022), 1-20, 12.2022
- Urheber
-
Wallen, Zachary D.
Demirkan, Ayse
Twa, Guy
Cohen, Gwendolyn
Dean, Marissa N.
Standaert, David G.
Sampson, Timothy R.
Payami, Haydeh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-34667-x
- URN
-
urn:nbn:de:101:1-2023012809364124053865
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wallen, Zachary D.
- Demirkan, Ayse
- Twa, Guy
- Cohen, Gwendolyn
- Dean, Marissa N.
- Standaert, David G.
- Sampson, Timothy R.
- Payami, Haydeh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microbiome changes: an indicator of Parkinson’s disease?
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
Diet and the gut microbiome in patients with Parkinson’s disease
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Microbiome changes: an indicator of Parkinson’s disease?
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
Diet and the gut microbiome in patients with Parkinson’s disease
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Microbiome changes: an indicator of Parkinson’s disease?
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
Diet and the gut microbiome in patients with Parkinson’s disease
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease